Private & confidential
Dr. Tang Yamei
Chinese name: 唐亚梅
Professor, Chief Physician, Researcher, Doctoral Supervisor, Vice President . Neurology & Cerebrovascular Disease
Dr. Yamei Tang is Vice President of Sun Yat-sen Memorial Hospital and academic leader of the Brain Research Centre and the Department of Neurology. A recipient of the National Science Fund for Distinguished Young Scholars and the Excellent Young Scientists Fund, she specialises in cerebrovascular disease, cerebral small-vessel disease and radiation-induced brain injury, and leads translational research in neurorepair.

Dr. Tang Yamei
more than 20
Years in neurology
31% to 65%
Response rate for radiation brain injury raised from
2019
National Science Fund for Distinguished Young Scholars
About Dr. Tang Yamei
Dr. Yamei Tang is Vice President of Sun Yat-sen Memorial Hospital and academic leader of the Brain Research Centre and the Department of Neurology. She has devoted her career to cerebrovascular disease, cerebral small-vessel disease and radiation-induced brain injury, and built one of China's largest clinical programmes for radiation-induced brain necrosis in nasopharyngeal carcinoma survivors. Her research on neuroinflammation, microglial senescence and neurorepair has been published in leading journals, and she has served as a principal investigator of national research projects. She is a recipient of the National Science Fund for Distinguished Young Scholars.

1、Vice President of Sun Yat-sen Memorial Hospital
2、Academic leader of the Brain Research Centre and the Department of Neurology
3、Recipient of the National Science Fund for Distinguished Young Scholars (2019) and the National Excellent Young Scientists Fund (2016)
4、Council member of the Chinese Neuroscience Society
5、Leading researcher on radiation-induced brain injury and cerebral small-vessel disease
6、Principal investigator of national research projects on neurorepair
Dr. Tang Yamei ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Radiation-induced brain injury
She diagnoses and treats radiation-induced brain necrosis in patients treated for nasopharyngeal carcinoma and other head and neck tumours, using bevacizumab, corticosteroids and individualised strategies to reduce brain oedema, preserve neurological function and improve long-term survival and quality of life.
Cerebral small-vessel disease
She evaluates and manages cerebral small-vessel disease and vascular cognitive impairment, integrating imaging, biomarkers and risk-factor control to slow disease progression, prevent recurrent stroke and cognitive decline, and guide long-term individualised care for older patients living with chronic cerebrovascular disease.
Acute ischaemic stroke
She provides emergency and comprehensive care for acute ischaemic stroke, including thrombolysis, endovascular treatment and secondary prevention, and leads clinical and translational research on reperfusion therapy that aims to improve functional recovery and outcomes for patients with acute cerebrovascular events.
More: cerebral haemorrhage——management; carotid stenosis——evaluation; dizziness and headache——diagnosis; neurorehabilitation——recovery; cognitive impairment——assessment
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Bevacizumab for Radiation-Induced Brain Injury
Professor Tang’s team found that bevacizumab significantly improves radiation-induced brain injury, a serious complication after radiotherapy for head and neck cancer. The treatment raised the response rate from about 31% to 65%, giving patients with cognitive decline or seizures after radiotherapy a more effective therapeutic option.
Related link: https://www.gzsys.org.cn/article/35691
2. PEARL Trial: Intra-Arterial Thrombolysis after Thrombectomy
Professor Tang led the PEARL multicentre randomised trial, testing intra-arterial alteplase after successful thrombectomy in acute ischaemic stroke. Published in JAMA, it showed that giving rt-PA into the artery within 24 hours safely improved neurological outcomes, offering a milestone treatment strategy for stroke patients with remaining microcirculation problems.
3. Thalidomide for Radiation-Induced Blood-Brain Barrier Injury
Professor Tang’s group showed that thalidomide can rescue blood-brain barrier damage and improve brain perfusion in patients with radiation-induced brain injury who respond poorly to steroids or bevacizumab. The phase 2 study, published in Science Translational Medicine, provides a new therapeutic option for refractory radiation brain injury patients.
Related link: https://www.gzsys.org.cn/article/24317
4. Microglia and CD8+ T Cells in Brain Injury
Professor Tang’s team revealed in Neuron that after radiation, microglia release chemokines CCL2 and CCL8 that recruit CD8+ T cells into the brain, causing secondary damage. Blocking this pathway reduced lesion size, opening a new immune-based treatment direction for radiation-induced brain injury and ischaemic stroke patients.
Related link: https://yyk.familydoctor.com.cn/yyzx/829/141.html
5. Blood Pressure Drugs and Dementia Risk
Professor Tang’s research explored how antihypertensive treatment relates to cognitive decline and dementia risk. By analysing large patient groups, her team found that controlling blood pressure may help protect brain health, offering practical guidance for older patients worried about memory loss and vascular dementia.
Related link: https://paper.sciencenet.cn/htmlnews/2022/7/483583.shtm
6. Radiation Nerve Injury Centre and Brain Bank
Professor Tang built one of the world’s largest cohorts and tissue banks for radiation-induced nervous system injury, and leads a leading treatment centre for radiation brain injury. This platform supports research and clinical care, helping patients with radiation-related cognitive problems receive accurate diagnosis and coordinated therapy.
Related link: http://www.sysu.edu.cn/news/info/2161/1114181.htm
Where Dr. Tang Yamei practices

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Chinese name: 中山大学孙逸仙纪念医院
Sun Yat-sen Memorial Hospital, founded in 1835 as China's first Western hospital and now a Grade-A tertiary hospital, operates 3,013 beds with 5,700 staff, holding 17 national key specialties, 7 national key disciplines and four-organ transplant licenses, performing 150,000+ annual surgeries.
Since 1835
191 years of care
3,013
Licensed beds
150,000+
Annual surgeries
17
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Tang Yamei?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Sun Yat-sen Memorial Hospital Official Expert Page: https://www.gzsys.org.cn/node/14700
- PubMed Author Records (radiation-induced brain necrosis and cerebral small-vessel disease): https://pubmed.ncbi.nlm.nih.gov/40616328/
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Tang Yamei.